| Name | Title | Contact Details |
|---|
Temperature Control Solutions for Laboratory and Production from -125 °C to +425 °C
Esperance Pharmaceuticals, Inc. is developing a new class of targeted oncology products that selectively kill cancer cells without harming normal cells. Targeting occurs through binding to specific receptors on the cancer cell surface. The novel product candidates destroy dividing and non-dividing cancer cells including those known to be resistant to chemotherapeutics.
BioProgress Technology is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
VDDI Pharmaceuticals is a Brentwood, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.